74 results
Page 2 of 4
6-K
EX-99.1
54jk ykbq
9 Aug 23
SciSparc Ltd. Announces Proposed Underwritten Public Offering of Approximately $1.3 Million
7:30pm
6-K
EX-99.1
oxu5o
2 Aug 23
Report of Foreign Private Issuer
12:00am
6-K
EX-99.1
ium460q hv4wttij
16 Jun 23
Report of Foreign Private Issuer
9:09am
6-K
EX-10.3
uao03 qh70nh9b8htc8
4 Apr 23
SciSparc completes the sale of a 49% interest in its Subsidiary that owns Wellution for $3 million
7:07am
6-K
EX-99.3
0z1rb d1hsl
30 Sep 22
SciSparc Enters Agreement to Acquire Wellution™, Top Seller of American Food Supplements and Cosmetics Brand on Amazon, for $20 million
7:27am
6-K
EX-99.1
wtas6n
11 Aug 22
Current Report
4:05pm
6-K
EX-99.1
ohrjb9lvejv1beafjh8u
7 Jul 22
Report of Foreign Private Issuer
4:00pm
6-K
EX-99.1
oma 62umxmf7u9
24 Jun 22
SciSparc Announces Ethics Committee Approval to Conduct its Clinical Trial in Autism Spectrum Disorder
8:52am
6-K
EX-99.4
et8i o2x6
27 May 22
SciSparc Announces Pricing of $10 Million Private Placement Priced At-the-Market
4:10pm
6-K
1kxel5go1h
22 Feb 22
Report of Foreign Private Issuer
9:05am
6-K
EX-99.1
mw23b
4 Jan 22
SciSparc Issued U.S. Patent For Its Core Technology That Treats Central Nervous Systems Disorders
4:42pm
POS AM
h0wvnakg02aghe0ts3b
8 Oct 21
Prospectus update (post-effective amendment)
12:00am
POS AM
m3quz zq705shg2
27 Aug 21
Prospectus update (post-effective amendment)
12:00am
POS AM
rz71rsw
27 Aug 21
Prospectus update (post-effective amendment)
12:00am
F-1/A
9qqd 7qo0khrf48y7
28 Apr 21
Registration statement (foreign) (amended)
4:38pm
F-1
e21a 4j3uh7jnurhdj7
21 Apr 21
Registration statement (foreign)
4:17pm
POS AM
6oksc
31 Mar 21
Prospectus update (post-effective amendment)
12:00am
POS AM
jv2v hx2vqdwp5x4j
31 Mar 21
Prospectus update (post-effective amendment)
12:00am